“…Bacterial infections are seriously threatening human life and health worldwide, and people must pay great attention to them. − Currently, commonly used antimicrobial therapy is reliant on a broad-spectrum strategy, namely, the use of commercially available antibiotics, which, if overused, may generate multidrug-resistant bacteria or resistant biofilms. − As such, innovative antimicrobial research has become extremely significant . Despite drastic advances in developing different antibacterial agents (e.g., metal nanomedicine, − strong oxidant, , heat, ,, antimicrobial peptides, ,, or catalytic treatment − ) to avoid drug resistance, infections still often cannot be effectively treated, primarily because of the passive diffusion of these agents leading to poor or even no matter–bacteria interactions. − Therefore, improving the mobility of antibacterial agents to break the bottleneck in infection treatment is challenging.…”